Health News
Date: Jan-23-2013
1 in 7 boys born in 2015 will be diagnosed with prostate cancer during his lifetime, compared with 1 in 20 in 1990, according to the latest figures from Cancer Research UK, who suggest the main reason is the increased use of the PSA test, plus the fact men are living longer. But against this backdrop is the good news that deaths to the disease are falling: in the last 20 years they have dropped by 18%. The charity released their latest figures on Wednesday...
Date: Jan-23-2013
A new brain-imaging technique has been developed to identify chronic traumatic encephalopathy (CTE) in living patients. Sports-related head injuries and mild traumatic brain injuries have been plastered among headlines during the previous few months, informing the public of long-term damage that has become more apparent among former and current athletes - most notably, professional football players...
Date: Jan-23-2013
Women of childbearing age should be screened for domestic abuse and intimate partner violence while visiting their doctor. The recommendation came from the U.S. Preventive Services Task Force (USPSTF) and was published in the journal Annals of Internal Medicine. The new suggestion represents a considerable change from 2004 when the USPSTF found inadequate proof to advocate screenings for intimate partner violence (IPV)...
Date: Jan-23-2013
Combination of school, community policy changes could help young people meet national recommendations for daily physical activity Requiring daily physical education in school could help young people be active for 23 minutes per day, which is more than a third of the total amount of daily physical activity experts recommend for young people. The new estimates were published in a study released today in the American Journal of Preventive Medicine...
Date: Jan-23-2013
Epilepsy health services in England are not good enough and vary in many areas, according to a report published today by national charity Epilepsy Action. This is despite the fact that almost half a million people in England currently live with the condition. � Epilepsy Action's report, A Critical Time for Epilepsy in England, draws on information collected from acute trusts, healthcare commissioners, local authorities and almost 1,000 people with epilepsy. It is the biggest published epilepsy report to date...
Date: Jan-23-2013
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal). "We found that women with hypertensive disorders during pregnancy were at higher risk of end-stage renal disease than women without complicated pregnancies," writes Dr. I-Kuan Wang, Division of Nephrology, China Medical University Hospital, Taichung, Taiwan, with coauthors...
Date: Jan-23-2013
Research published today in The Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.� Research published in 2009 showed that maternal valproate use during pregnancy affected children's IQ at three years old, leading the US Food and Drug Administration (FDA) to issue a warning that foetal valproate exposure is associated with impaired cognitive outcomes...
Date: Jan-23-2013
NextLevel Pharma's "Advancing clinical research in Turkey, the Middle East and North Africa" will bring together the local regulators and ethics committees, alongside experienced investigators and study personnel as well as clinical trial experts from pharma and CROs. It will examine in detail, the key regulatory, clinical, outsourcing and environmental factors which impact the clinical trials. Particular and specific attention will be given to Turkey, Egypt, Saudi Arabia, the Gulf States, Jordan & Lebanon via separate, focused, streamed conference sessions...
Date: Jan-23-2013
This will be a very unique event that will provide participants with an overview on the best practices in clinical data management for today's clinical context. The event will present the perspectives of experienced professionals from large and small pharma companies including case-study experiences and panel discussions from experts who have successfully overcome challenges to develop successful CDM strategies. Why Attend? Learn how the industry is adapting to the changing regulatory environment and demands for clinical data from today's new stakeholders...
Date: Jan-23-2013
This event will enable all participants the opportunity to hear from leading industry experts as well as key stakeholders in the market access process for their products. It will deliver the ability to make decisions as to which markets to prioritise and shed light on the optimal market access process in these markets. Why attend? Hear real-life examples of successful CEE & Russia market implementation from device companies Hear which reforms are taking place now in key CEE countries. Learn which innovative reimbursement schemes can be implemented in CEE...